BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

542 hedge funds and large institutions have $18B invested in BioMarin Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 85 funds opening new positions, 176 increasing their positions, 204 reducing their positions, and 50 closing their positions.

Holders
542
Holders Change
+28
Holders Change %
+5.45%
% of All Funds
7.95%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.21%
New
85
Increased
176
Reduced
204
Closed
50
Calls
$193M
Puts
$141M
Net Calls
+$51.4M
Net Calls Change
-$923K

Top Buyers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.04B
2
EIM
2
Elliott Investment Management
Florida
$289M
3
Deutsche Bank
3
Deutsche Bank
Germany
$328M
4
Morgan Stanley
4
Morgan Stanley
New York
$181M
5
Millennium Management
5
Millennium Management
New York
$113M

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$0
2
Nomura Holdings
2
Nomura Holdings
Japan
$206M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$269M
4
Pictet Asset Management
4
Pictet Asset Management
Switzerland
$139M
5
Parnassus Investments
5
Parnassus Investments
California
$178M
Name Market Value Shares Shares
Change 		Shares
Change %
Primecap Management
1
Primecap Management
California
$1.78B 18,414,374 +7,835 +0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.74B 18,050,062 +348,852 +2%
BlackRock
3
BlackRock
New York
$1.42B 14,681,644 +74,457 +0.5%
Dodge & Cox
4
Dodge & Cox
California
$1.35B 13,994,063 -159,440 -1%
Capital Research Global Investors
5
Capital Research Global Investors
California
$1.04B 10,774,641 +4,756,671 +79%
State Street
6
State Street
Massachusetts
$649M 6,730,515 +271,786 +4%
Ameriprise
7
Ameriprise
Minnesota
$523M 5,419,366 +255,417 +5%
Barclays
8
Barclays
United Kingdom
$510M 5,288,893 -284,264 -5%
Viking Global Investors
9
Viking Global Investors
Connecticut
$471M 4,889,454 +673,998 +16%
ACA
10
Avoro Capital Advisors
New York
$415M 4,300,000 +450,000 +12%
Deutsche Bank
11
Deutsche Bank
Germany
$328M 3,402,197 +2,003,478 +143%
Norges Bank
12
Norges Bank
Norway
$324M 3,361,310 +318,010 +10%
EIM
13
Elliott Investment Management
Florida
$289M 3,000,338 +3,000,338 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$276M 2,872,432 +109,996 +4%
Janus Henderson Group
15
Janus Henderson Group
United Kingdom
$269M 2,790,343 -634,196 -19%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$247M 2,560,239 +165,099 +7%
JPMorgan Chase & Co
17
JPMorgan Chase & Co
New York
$236M 2,447,792 -171,040 -7%
Bank of America
18
Bank of America
North Carolina
$227M 2,358,865 -36,356 -2%
Nomura Holdings
19
Nomura Holdings
Japan
$206M 2,132,937 -707,873 -25%
Morgan Stanley
20
Morgan Stanley
New York
$181M 1,880,744 +1,119,237 +147%
Parnassus Investments
21
Parnassus Investments
California
$178M 1,849,348 -489,181 -21%
T. Rowe Price Associates
22
T. Rowe Price Associates
Maryland
$155M 1,605,983 +401,152 +33%
O
23
OrbiMed
New York
$152M 1,571,410 -43,800 -3%
PAI
24
Palo Alto Investors
California
$145M 1,500,749 -330,286 -18%
Pictet Asset Management
25
Pictet Asset Management
Switzerland
$139M 1,436,723 -505,522 -26%
1
2 3 4 5